Injection directly into muscle tissue, typically in the deltoid, vastus lateralis, or gluteus.
Used for peptides requiring faster systemic onset than subcutaneous delivery or for depot formulations whose oil vehicle is irritating to subcutaneous tissue. Most therapeutic peptides do not require IM administration.